An integrated quantification method to increase the precision, robustness, and resolution of protein measurement in human plasma samples

Table 5 Pearson correlation coefficient of protein abundance between Study I and a discovery study ^a

Protein (HUMAN)	InteQuan vs. EPN	InteQuan vs. Raw	EPN vs. EPN	EPN vs. Raw	SISQuan vs. EPN	SISQuan vs. Raw	Raw vs. EPN	Raw vs. Raw
KIT	0.711	0.536	0.560	0.404	0.270	0.434	0.196	0.290
FRIL	0.953	0.829	0.850	0.781	0.815	0.857	0.721	0.791
COIA1	0.770	0.610	0.715	0.605	0.679	0.735	0.626	0.646
PRDX1	0.978	0.971	0.946	0.943	0.950	0.975	0.937	0.956
TENX	0.831	0.690	0.800	0.711	0.607	0.683	0.551	0.615
ENPL	0.648	0.652	0.629	0.638	0.499	0.647	0.432	0.560
GRP78	0.649	0.618	0.620	0.656	0.444	0.624	0.367	0.597
BGH3	0.521	0.364	0.216	0.202	0.284	0.523	0.204	0.363
ALDOA	0.900	0.882	0.868	0.847	0.865	0.899	0.826	0.870
GGH	0.835	0.622	0.830	0.666	0.656	0.717	0.745	0.755
CD14	0.841	0.395	0.588	0.412	0.543	0.642	0.330	0.411
LG3BP	0.921	0.836	0.833	0.772	0.904	0.935	0.854	0.911
TSP1	0.909	0.802	0.876	0.750	0.918	0.902	0.918	0.884
IBP3	0.811	0.664	0.750	0.598	0.515	0.609	0.457	0.486
TETN	0.418	0.416	0.277	0.289	0.353	0.551	0.443	0.581
ISLR	0.783	0.651	0.700	0.637	0.554	0.712	0.500	0.624
Median	0.821	0.652	0.733	0.647	0.581	0.698	0.526	0.620

^aEvaluated on the 55 common clinical samples between the two studies and labeled as method on data of Study I versus method on data of the discovery study.

ISSN: 1559-0275